Natco Pharma completes acquisition of Newark Drugs
Natco Pharma has reported the completion of purchase of assets of Newark Drugs, a retail pharmacy store based in Newark, New Jersey, US.
Network Drugs was acquired by K&C Pharmacy, a US based general partnership firm, in which Natco holds 75 per cent stake. Newark Drugs reports $5 million in annual sales.
Through this acquisition Natco's revenues from US retail aggregates was $35 million in a full year. The company has plans to acquire a few more stores to strengthen its presence in US retail markets.
At 12:16 pm, Natco Pharma shares were down 1.52 per cent at Rs 116.50 on BSE.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.